Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1691-1700 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|June 18, 2020
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemicKewen Qian, Shi Hu
Mabs|June 17, 2020
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffoldZehua Sun, Chuan Chen, Wei Li, et al.
Mabs|September 17, 2021
Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settingsEva Germovsek, Ming Cheng, Craig Giragossian
Mabs|October 22, 2019
Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometryChristoph Gstöttner, Dietmar Reusch, Markus Haberger, et al.
Mabs|April 25, 2020
<i>In vitro</i> affinity optimization of an anti-BDNF monoclonal antibody translates to improved potency in targeting chronic pain states <i>in vivo</i>Edwina Stack, Sheridan McMurray, Gordon McMurray, et al.
Mabs|April 21, 2020
Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissuesKip P Conner, Cinthia V Pastuskovas, Marcus Soto, et al.
Mabs|September 6, 2021
Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugateDifei Qiu, Yande Huang, Naresh Chennamsetty, et al.
Mabs|September 24, 2025
A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biologyShahzada Khan, Jeremy Lum, Heather Stephenson, et al.
Mabs|September 15, 2025
Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeuticsMatthew A Cruz, Marco Blanco, Iriny Ekladious
Mabs|August 14, 2025
Pioneer: a synthetic human antibody phage display library for rapid therapeutic lead generationMateusz Putyrski, Christian Hentrich, Manuel Cavada, et al.
Pageof 178

Showing results (1691-1700 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|June 18, 2020
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemicKewen Qian, Shi Hu
Mabs|June 17, 2020
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffoldZehua Sun, Chuan Chen, Wei Li, et al.
Mabs|September 17, 2021
Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settingsEva Germovsek, Ming Cheng, Craig Giragossian
Mabs|October 22, 2019
Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometryChristoph Gstöttner, Dietmar Reusch, Markus Haberger, et al.
Mabs|April 25, 2020
<i>In vitro</i> affinity optimization of an anti-BDNF monoclonal antibody translates to improved potency in targeting chronic pain states <i>in vivo</i>Edwina Stack, Sheridan McMurray, Gordon McMurray, et al.
Mabs|April 21, 2020
Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissuesKip P Conner, Cinthia V Pastuskovas, Marcus Soto, et al.
Mabs|September 6, 2021
Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugateDifei Qiu, Yande Huang, Naresh Chennamsetty, et al.
Mabs|September 24, 2025
A highly selective TCR-mimic antibody reveals unexpected mechanisms of HBV peptide-MHC recognition and previously unknown target biologyShahzada Khan, Jeremy Lum, Heather Stephenson, et al.
Mabs|September 15, 2025
Mechanistic and predictive formulation development for viscosity mitigation of high-concentration biotherapeuticsMatthew A Cruz, Marco Blanco, Iriny Ekladious
Mabs|August 14, 2025
Pioneer: a synthetic human antibody phage display library for rapid therapeutic lead generationMateusz Putyrski, Christian Hentrich, Manuel Cavada, et al.
Pageof 178